Room A
ESMO Colloquium
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Location
Room A
Chairs
- D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
ESMO Colloquium
Introduction
Lecture Time
11:45 - 11:50
Speakers
- D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
- D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
ESMO Colloquium
First-line immunotherapy options for patients without an oncogene driver
Lecture Time
11:50 - 12:10
Speakers
- R. Califano (Manchester, United Kingdom)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
- R. Califano (Manchester, United Kingdom)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
ESMO Colloquium
What is the biological rationale for combining chemotherapy with immune checkpoint inhibitors?
Lecture Time
12:10 - 12:30
Speakers
- M. Garassino (Milan, Italy)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
- M. Garassino (Milan, Italy)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
ESMO Colloquium
Are immune checkpoints (ICPs) better as single agent, doublet ICPs or combined with chemo +/- anti-angiogenics?
Lecture Time
12:30 - 12:50
Speakers
- S. Peters (Lausanne, Switzerland)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
- S. Peters (Lausanne, Switzerland)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
ESMO Colloquium
Recommendation on second-line treatment according to first-line choice
Lecture Time
12:50 - 13:10
Speakers
- D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
- D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy?
ESMO Colloquium
Conclusion
Lecture Time
13:10 - 13:15
Speakers
- D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
- D. Planchard (Villejuif, France)